Logos Global Management LP Xenon Pharmaceuticals Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $13.6 Million - $16.4 Million	375,000 New	375,000 $14.6 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $8.61 Million - $13.9 Million	-300,000 Reduced 66.67%	150,000 $6.91 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $5.98 Million - $6.95 Million	175,000 Added 63.64%	450,000 $15.4 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $21.8 Million - $27.2 Million	-625,000 Reduced 69.44%	275,000 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $13.2 Million - $15.8 Million	400,000 Added 80.0%	900,000 $35.5 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $15.4 Million - $19.9 Million	500,000 New	500,000 $18.1 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.